For the Inventor, By the Inventor

Enter inventor name

Jerusalem, Israel

Boris Yagen

USPTO Granted Patents = 12 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 25(Granted Patents)

Company Filing History:

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Years Active: 1999-2014

Loading Chart...

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8846903 - Acyl-urea derivatives and uses thereof (2014-09-30),

2. 8829242 - Amide derivatives of valproic acid and uses thereof (2014-09-09),

3. 8518979 - Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof (2013-08-27),

4. 8399708 - Compounds useful for treating bipolar disorders (2013-03-19),

5. 7232929 - Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid (2007-06-19),

6. 6969732 - Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them (2005-11-29),

7. 6960687 - Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and CNS activity, and method for their preparation (2005-11-01),

8. 6958416 - Valproyltaurinamide derivatives as anticonvulsant amd CNS active agents (2005-10-25),

9. 6630602 - Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them (2003-10-07),

10. 6417399 - Amelioration of neurological disorders by the administration of (2R),(3S), and/or (2S),3(S) stereoisomers of valnoctamide (2002-07-09),

11. 6323365 - Active derivative of valproic acid for the treatment of neurological and psychotic disorders and a method for their preparation (2001-11-27),

12. 5880157 - Derivatives of tetramethylcyclopropane (1999-03-09),

Title: The Innovative Contributions of Boris Yagen

Introduction

Boris Yagen is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of neurological treatments, holding a total of 12 patents. His work focuses on developing novel compounds that address various neurological diseases and disorders.

Latest Patents

Among his latest patents are the acyl-urea derivatives and their uses. These novel acyl-urea containing compounds are designed for the treatment of neurological diseases such as epilepsy, neuropathic pain, bipolar disorder, and status epilepticus. Additionally, they are aimed at addressing chemically-induced convulsions, febrile convulsions, metabolic disturbances, and sustenance withdrawal conditions. Another significant patent involves amide derivatives of valproic acid, which are also intended for the treatment of epilepsy.

Career Highlights

Boris Yagen is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His innovative work has positioned him as a key figure in the research and development of treatments for complex neurological conditions.

Collaborations

Throughout his career, Yagen has collaborated with notable colleagues, including Meir Bialer and Dan Kaufmann. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

Boris Yagen's contributions to the field of neurological treatments through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…